Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Research crawled date : 2022 - 11 - 01 save search
electroCore and Joerns Healthcare Partner to Expand Use Of gammaCore™ Vagus Nerve Technology for Headache Sufferers
Published: 2022-11-01 (Crawled : 19:00) - biospace.com/
ECOR | $5.41 -1.82% -1.85% 14K
|
Health Technology
|
| O: 0.0%
H: 26.78%
C: 13.33%
technology
Research Solutions to Announce First Quarter Fiscal 2023 Results on Thursday, November 10, 2022
Published: 2022-11-01 (Crawled : 18:00) - prnewswire.com
RSSS 4 | $3.07 0.33% 0.33% 22K
|
Commercial Services
|
| O: 0.52%
H: 1.29%
C: 0.77%
research solutions results
Denali Therapeutics Announces Phase 1/2 Study Single Dose Healthy Volunteer Data with TAK-594/DNL593 (PTV:PGRN) and Progression to Enrolling Participants with FTD-GRN
Published: 2022-11-01 (Crawled : 13:00) - biospace.com/
DNLI | $16.81 -3.06% -3.15% 1.4M
|
Health Technology
|
| O: 3.1%
H: 3.52%
C: -2.06%
tak-594 ftd-grn therapeutics study phase 1
Cerus Corporation Announces Health Canada Approval for INTERCEPT Blood System for Platelets with Seven-Day Storage
Published: 2022-11-01 (Crawled : 13:00) - biospace.com/
CERS | $1.63 -2.98% -3.07% 750K
|
Health Technology
|
| O: 3.01%
H: 0.0%
C: -2.12%
blood system canada health approval corporation
Blueprint Medicines Outlines 2027 Blueprint to Achieve Precision Medicine at Scale and Reports Third Quarter 2022 Financial Results at Investor Day 2022
Published: 2022-11-01 (Crawled : 13:00) - biospace.com/
BPMC | $88.395 2.68% 2.61% 730K
|
Health Technology
|
| O: 3.8%
H: 0.0%
C: -10.35%
day financial results
Global 5G Security Market Share Estimated to Reach USD 21.11 Billion by 2030, with a CAGR of 41.4%: Polaris Market Research
Published: 2022-11-01 (Crawled : 13:00) - prnewswire.com
T | $16.12 0.19% 0.12% 27M
|
Communications
|
| O: 1.87%
H: 0.05%
C: -1.18%
QCOM | $164.17 -2.62% -2.69% 8.1M
|
Electronic Technology
|
| O: 1.77%
H: 0.74%
C: -2.01%
INTC | $35.66 -1.65% -1.68% 41M
|
Electronic Technology
|
| O: 1.3%
H: 0.17%
C: -1.74%
ERIC | News | $4.93 1.03% 1.01% 29M
|
Electronic Technology
|
| O: 1.08%
H: 0.44%
C: -1.07%
CHKP | $158.18 0.88% 0.87% 650K
|
Technology Services
|
| O: 0.6%
H: 0.55%
C: -0.15%
research global security market
CymaBay Announces Appointment of Charles McWherter, Ph.D. to Chief Scientific Officer and President of Research and Development
Published: 2022-11-01 (Crawled : 12:20) - globenewswire.com
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: -1.44%
H: 6.41%
C: 3.5%
research
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
CDNA | $8.28 5.48% 5.19% 2M
|
Health Technology
|
| O: 1.81%
H: 2.17%
C: -1.09%
kidney study
Xeris Biopharma Announces Results of the Extended Evaluation of Recorlev® (Levoketoconazole) From the Phase 3 Sonics Study Published in the European Journal of Endocrinology
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
XERS | $1.79 -0.56% -0.56% 1.5M
|
Health Technology
|
| O: 0.63%
H: 1.24%
C: -1.24%
recorlev biopharma results study
HARMONY BIOSCIENCES ANNOUNCES TOPLINE RESULTS FROM PHASE 2 PROOF-OF-CONCEPT STUDY EVALUATING PITOLISANT FOR EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH PRADER-WILLI SYNDROME
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HRMY | $29.19 -1.98% -2.02% 330K
|
Health Technology
|
| O: 5.1%
H: 8.45%
C: 8.44%
topline study
Veeva and Merck Form Long-Term Strategic Partnership
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
VEEV | News | $199.2 -0.58% 0.0% 1M
|
Technology Services
|
| O: 1.85%
H: 0.19%
C: -4.26%
MRK | $125.37 0.25% 0.1% 6.1M
|
Health Technology
|
| O: -0.54%
H: 0.42%
C: -0.88%
partnership
Monte Rosa Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating MRT-2359, a GSPT1-directed Molecular Glue Degrader, for Treatment of MYC-driven Tumors
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
GLUE | $5.8 -4.29% -4.48% 110K
|
Professional, Scientific, and T...
|
| O: 1.41%
H: 0.86%
C: -3.22%
mrt-2359 treatment rosa trial therapeutics tumors molecular
NewHydrogen further expands green hydrogen technology research program at UCLA
Published: 2022-11-01 (Crawled : 08:00) - globenewswire.com
NEWH | $0.0065 67.57% 1.2M
|
Manufacturing
|
| O: 6.25%
H: 0.0%
C: -14.71%
research program technology hydrogen
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.